Experts in Excipients
MEGGLE Excipients & Technology is a manufacturer of lactose for the pharmaceutical industry. With manufacturing facilities in Europe and US, MEGGLE offers a broad product portfolio of lactose excipients.
Experts in Excipients
MEGGLE Excipients & Technology is a global leader in the manufacture of lactose for the pharmaceutical industry. Supporting supply chain security with manufacturing facilities in Europe and North America, MEGGLE offers a broad product portfolio of lactose excipients, co-processed technologies and excipient contract manufacturing.
MEGGLE is a pioneer in co-processing technologies that allow simple, robust formulation development and manufacture. Through co-processing, MEGGLE developed highly functional excipients possessing unique qualities for directly compressible immediate and sustained release pharmaceutical solid dosage forms.
As a family owned, German company, MEGGLE has proudly produced quality products for consumers and industry for four generations.
MEGGLE Excipients & Technologies serves the pharmaceutical and biotechnology markets with a global network of offices and authorized agents. As an innovator in co-processed technology, MEGGLE also provides contract manufacturing services to several other global excipient companies.
Our broad portfolio of products, multiple manufacturing locations, technical centers in major markets, and innovative technologies, make MEGGLE the preferred supplier and valued partner by large and small pharmaceutical product manufacturers.
MEGGLE Excipients & Technologies excipient products:
- Lactose monohydrate
- Anhydrous Lactose
- Co-Processed Excipients
- Lactose for Inhalation
- Lactose for lyophilization and parenteral applications
- Custom lactose products
Company name: Molkerei MEGGLE Wasserburg GmbH & Co. KG
Website: www.meggle-pharma.deE-mail: service.pharma@meggle.de
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
